Search

everythinglearnresearchcommunity

for

Search:↓

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Hair loss in women linked to higher sexual dysfunction risk.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Girls conceived via assisted reproductive technologies show early puberty signs and larger ovaries.

Participating in Sexual Orientation Change Efforts may increase the risk of suicide for sexual minority individuals.

Certain medications can reduce sexual desire and function, especially in women.

Some medications can help increase sexual desire and function in women.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Finasteride for hair loss may cause long-lasting sexual side effects in young males.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Women with PCOS often feel stigmatized and have mood issues, which can lower their sexual satisfaction, but proper treatment and support can help.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Finasteride for hair loss has minimal impact on sexual function.

Finasteride may cause sexual side effects like erectile dysfunction, but they are reversible and affect less than 2% of men.